Literature DB >> 23661103

Natriuretic peptides as biomarkers in heart failure.

James L Januzzi1.   

Abstract

Following the initial discovery of a natriuretic and diuretic peptide factor present in atrial myocardial tissue homogenates, subsequent elucidation of the natriuretic peptide (NP) family has led to substantial advances in the understanding of the autocrine, paracrine, and endocrine regulation of the cardiovascular system. Furthermore, with the development of assays for the measurement of the NPs, these important biomarkers have gone from being regarded as biological mediators of the cardiovascular system to now represent important clinical tools for the diagnostic and prognostic evaluation of patients with heart failure and may have potential as a therapeutic target in this setting as well. An historical perspective on the NPs from bench to bedside translation will be discussed.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23661103      PMCID： PMC4145592          DOI： 10.2310/JIM.0b013e3182946b69

Source DB:  PubMed          Journal:  J Investig Med        ISSN： 1081-5589            Impact factor:   2.895


  56 in total

1.  Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin.

Authors:  Y Sawada; M Suda; H Yokoyama; T Kanda; T Sakamaki; S Tanaka; R Nagai; S Abe; T Takeuchi
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  Human brain natriuretic peptide, a novel cardiac hormone.

Authors:  M Mukoyama; K Nakao; Y Saito; Y Ogawa; K Hosoda; S Suga; G Shirakami; M Jougasaki; H Imura
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

3.  Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes.

Authors:  N Tamura; Y Ogawa; A Yasoda; H Itoh; Y Saito; K Nakao
Journal:  J Mol Cell Cardiol       Date:  1996-08       Impact factor: 5.000

4.  Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.

Authors:  K Yamamoto; J C Burnett; M M Redfield
Journal:  Am J Physiol       Date:  1997-11

5.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

6.  The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs.

Authors:  T Seidler; C Pemberton; T Yandle; E Espiner; G Nicholls; M Richards
Journal:  Biochem Biophys Res Commun       Date:  1999-02-16       Impact factor: 3.575

7.  Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues.

Authors:  A L Gerbes; L Dagnino; T Nguyen; M Nemer
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

8.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.

Authors:  Anju Bhardwaj; Shafiq U Rehman; Asim A Mohammed; Hanna K Gaggin; Linda Barajas; Justine Barajas; Stephanie A Moore; Dorothy Sullivan; James L Januzzi
Journal:  Am Heart J       Date:  2012-11       Impact factor: 4.749

10.  Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes.

Authors:  M C LaPointe; G Wu; M Garami; X P Yang; D G Gardner
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190
View more
  8 in total

1.  Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure.

Authors:  Juan F Delgado; Andreu Ferrero Gregori; Laura Morán Fernández; Ramón Bascompte Claret; Andrés Grau Sepúlveda; Francisco Fernández-Avilés; José R González-Juanatey; Rafael Vázquez García; Miguel Rivera Otero; Javier Segovia Cubero; Domingo Pascual Figal; Maria G Crespo-Leiro; Jesús Alvarez-García; Juan Cinca; Fernando Arribas Ynsaurriaga
Journal:  Curr Heart Fail Rep       Date:  2019-12

2.  [GDF-15 in plasma and circulating mononuclear cells and NT-proBNP for diagnosis of chronic heart failure and predicting cardiovascular disease events].

Authors:  Qiao Xiangrui; Liu Junhui; Hua Rui; Zhuo Xiaozhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

3.  Biliary cirrhosis-induced cardiac abnormality in rats: Interaction between Farnesoid-X-activated receptors and the cardiac uncoupling proteins 2 and 3.

Authors:  Gholamreza Bayat; Seyed Ali Hashemi; Hosein Karim; Parviz Fallah; Keshvad Hedayatyanfard; Mahnaz Bayat; Azadeh Khalili
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

Review 4.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

5.  Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.

Authors:  Shweta R Motiwala; Jackie Szymonifka; Arianna Belcher; Rory B Weiner; Aaron L Baggish; Hanna K Gaggin; Anju Bhardwaj; James L Januzzi
Journal:  J Cardiovasc Transl Res       Date:  2013-12-06       Impact factor: 4.132

6.  Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy.

Authors:  Santiago Roura; Carolina Gálvez-Montón; David de Gonzalo-Calvo; Ana Gámez Valero; Paloma Gastelurrutia; Elena Revuelta-López; Cristina Prat-Vidal; Carolina Soler-Botija; Aida Llucià-Valldeperas; Isaac Perea-Gil; Oriol Iborra-Egea; Francesc E Borràs; Josep Lupón; Vicenta Llorente-Cortés; Antoni Bayes-Genis
Journal:  J Cell Mol Med       Date:  2017-05-29       Impact factor: 5.310

Review 7.  Novel Biomarkers of Renal Dysfunction and Congestion in Heart Failure.

Authors:  Agata Zdanowicz; Szymon Urban; Barbara Ponikowska; Gracjan Iwanek; Robert Zymliński; Piotr Ponikowski; Jan Biegus
Journal:  J Pers Med       Date:  2022-05-29

8.  The Clinical and Health Economic Value of Clinical Laboratory Diagnostics.

Authors:  Bruce Jordan; Cheryl Mitchell; Andy Anderson; Norbert Farkas; Richard Batrla
Journal:  EJIFCC       Date:  2015-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.